Brief: Infant Bacterial Therapeutics Q2 oper loss at SEK 13.8 mln
Aug 28 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB
IBTb.ST
* Q2 NET SALES 121 KSEK (-)
* Q2 OPERATING LOSS -13 826 KSEK (-10 975)
Source text for Eikon: ID:nGNE3YSHKc
Further company coverage: IBTb.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln